baber/WOPTO huggingface dataset:
Patent NZ-544841-A (NZ)
Title: Opening devices for foil closures
Inventor: VON SPRECKELSEN HENNING
IPC: B65D47/10
Filed: 2004-08-05
Abstract: An opening device for a foil closure that can be fitted to a container body is disclosed. The device comprises a spout with a removable disc attached to a pull-ring. The disc is secured to the spout by means of a frangible region (30). A foil is sealed to a raised land on a base of the disc. The pull ring is mounted to the disc by means of legs (54) so that it applies a force on a peninsula (50) of the disc, thereby reducing the length of the arc over which an initial pulling force is dissipated when the initial tear is being initiated reducing the force required to tear the foil by up to 40%.
Patent NZ-553170-A (NZ)
Title: Physiologically active composition for treating diabetes
Inventor: JAGER RALF
IPC: A23L33/00
Filed: 2005-07-21
Abstract: Disclosed is the use of a physiologically active composition comprising effective amounts of (i) at least one compound selected from 4-O-methyldavidigenin, 4'-O-methyldavidigenin, davidigenin, elemicin, isoelemicin, herniarin, demethoxycapillarisin, hispiludin, and 9-hydroxy-10E, 12Z, 15Z octadecatrienoic acid, as well as their glycosides and additionally (ii) at least one compound selected from chlorogenic acid, naringenin, flavonoids, flavanoids, terpenes and/or terpenoids for the manufacture of a medicament for the prevention and/or treatment of (pre)diabetes and concomitant and/or secondary diseases connected with diabetes, wherein the glycosides are selected from the group consisting of glucosides and/or rhamnoglucosides of 4-O-methyldavidigenin and/or 4'-O-methyldavidigenin as well as salts thereof, and wherein the prevention and/or treatment of (pre) diabetes and concomitant and secondary diseases connected with diabetes means reducing a) the blood sugar level in mammals, b) the insulin resistance, and/or c) the postprandial glucose level, and/or increasing d) the expression of insulin-receptor-substrate 2- polypeptide and/or e) the insulin controlled glucose uptake.
Patent NZ-553277-A (NZ)
Title: Novel azabicyclic aryl derivatives and their medical use
Inventor: PETERS DAN
IPC: A61K31/439
Filed: 2005-10-14
Abstract: The disclosure relates to an azabicyclo [2.2.2] octane derivative represented by Formula (I) any of its enantiomers or any mixture of its enantiomers, or a pharmaceutically salt thereof, wherin the substituents are defined as per the specification. Also disclosed is a pharmaceutical composition comprising said derivative and the use of said derivative for the manufacture of a medicament for the treatment of diseases, condition or disorders responsive to modulation of cholinergic receptors and/or monoamine receptors.
Patent NZ-553558-A (NZ)
Title: An optimized grating based biosensor with a birefringent substrate
Inventor: SCHULZ STEPHEN C
IPC: G02B6/34
Filed: 2006-04-06
Abstract: Disclosed is a biosensor comprising: a substrate, the substrate comprising a material having an optical axis (such as a birefringent substrate like PET); and a grating applied to the substrate, wherein the grating comprises features arranged in a plurality of parallel lines and wherein the lines of the grating are in substantial alignment with the optical axis of the substrate. Also disclosed is a method of manufacturing a biosensor, comprising the steps of: a) feeding a web of substrate material to a station, the web of substrate material having an optical axis; b) applying a grating to the substrate material at the station, wherein the grating comprises a plurality of parallel lines; wherein, in the performance of step (b), the grating is applied to the substrate in a manner whereby the lines of the grating are in substantial alignment with the optical axis of the web of substrate material.
Patent NZ-554280-A (NZ)
Title: Continuous method and apparatus for microwave-based dryer
Inventor: NOVAK JOHN F
Filed: 2005-09-15
Abstract: A continuous process for drying a material containing an initial degree of water is provided. The process includes the steps of: (a) driving a vehicle comprising a microwave apparatus over at least a portion of the material; (b) exposing the portion of the material to a heated applicator having an air flow about the portion of the material; (c) exposing the portion of the material to at least two sources of microwaves, which are in non-parallel alignment to each other for a period of time sufficient to dry the portion of the material to a lower degree of water. An apparatus for performing the process is also provided.
Patent NZ-564390-A (NZ)
Title: Quick paging channel with reduced probability of missed page
Inventor: AGRAWAL AVNEESH
IPC: H04W68/00
Filed: 2006-06-16
Abstract: A method of notifying an access terminal is disclosed. The method comprising: determining the presence of a scheduled message for the access terminal; setting a quick paging bit from a number of quick paging bits in a quick paging block, the quick paging bit corresponding to the access terminal; compressing the quick paging block to generate a compressed quick paging block; encoding the compressed quick paging block to generate an encoded quick paging packet; generating at least one Orthogonal Frequency Division Multiplex (OFDM) symbol having at least a portion of the encoded quick paging block; and transmitting the at least one OFDM symbol. Compressing the quick paging block comprises: determining a number of asserted quick paging bits from the plurality of quick paging bits; and generating successive fields indicating positions of the asserted quick paging bits within the quick paging block if the number of asserted bits is less than a predetermined amount.
Patent NZ-566968-A (NZ)
Title: Anti-frost film assemblies, method of manufacture, and articles made thereof
Inventor: BOROWIEC MATTHEW
IPC: C08J7/056
Filed: 2006-09-27
Abstract: Disclosed is an anti-frost assembly comprising a substantially transparent film having a first surface and a second surface opposite the first surface and a substantially transparent anti-frost layer formed from a polyurethane-film forming composition comprising a surfactant having an isocyanate-reactive moiety and a hydrophobic region and a hydrophilic region effective to provide the layer with anti-frost properties at temperatures that alternate between -23 degrees Celcius and 65 degrees Celcius, wherein the anti-frost layer is disposed on an area of the first surface of the film.
Patent NZ-568319-A (NZ)
Title: Implantation of encapsulated biological materials for treating diseases
Inventor: SCHARP DAVID
IPC: A61K35/12
Filed: 2003-10-14
Abstract: Disclosed is a method of encapsulating a biological material comprising: a) adding a solution comprising a first buffer to the biological material; b) centrifuging the biological material to form a pelleted biological material; c) removing supernatant; d) adding a solution comprising a photoinitiator dye conjugated to a cell adsorbing material to the pelleted biological material; e) resuspending and incubating the pelleted biological material with the solution comprising the photoinitiator dye conjugated to the cell adsorbing material for an effective amount of time; f) centrifuging mixture; g) removing the solution comprising the photoinitiator dye conjugated to the cell adsorbing material; h) resuspending the pelleted biological material with a second solution comprising a second buffer; i) centrifuging and removing the second buffer; j) resuspending and mixing the biological material with a photoactive polymer solution; and k) irradiating the resuspended biological material with a photoactive polymer solution with an energy source to form an encapsulated biological material.
Patent NZ-573730-A (NZ)
Title: Smoking article and a filter system comprising impaction filter with at least one plate having at least one orfice
Inventor: BRAUNSHTEYN MICHAEL
IPC: A24D3/04
Filed: 2007-07-12
Abstract: A filter system for a cigarette (10) is disclosed. The system comprises an upstream plug (42) of filtering material, an impaction filter (44) and a downstream plug (46) of filtering material. The impaction filter (44) comprises at least one plate having at least one orifice. There is a hollow tube filter (100) between the impaction filter (44) and the downstream plug (46).
Patent NZ-576986-A (NZ)
Title: Production and purification of recombinant arylsulfatase A
Inventor: FOGH JENS
IPC: A61K38/46
Filed: 2005-01-30
Abstract: Disclosed is a process for production of recombinant human arylsulphatase A in a continuous cell culture system, the process comprising: i) culturing a mammalian cell capable of producing arylsulfatase A in liquid medium in a system comprising one or more bio-reactors; ii) concentrating, purifying and formulating the rhASA by a purification process comprising one or more steps of affinity chromatography and/or ion exchange chromatography at a pH in the range of 7.2 to 4.8; wherein the concentration and purification process of (ii) comprises a polishing step around pH 6.0 including a passive step, wherein the arylsulfatase A passes through a cation exchange chromatography resin or membrane and/or affinity chromatography resin, and an active step, wherein the arylsulfatase A is detained within and subsequently eluted around pH 4.8 from an anion exchange membrane or resin, and wherein the cation exchange chromatography resin or membrane and the anion exchange membrane or resin are coupled or connected in a series.
Patent NZ-577912-A (NZ)
Title: Fluorescent cell markers
Inventor: BOVIN NICOLAI
IPC: C07D311/78
Filed: 2006-09-06
Abstract: Disclosed are water soluble fluorescent cell marker compounds of the structure F-S1-S2-L, where F is a fluorophore; S1-S2 is a spacer linking F to L; L is a lipid selected from diacyl- and dialkyl-glycerophospholipids; and the structure includes the substructure -C(=R1)-NH-(CH2)m-NH-C(=O)-(CH2)n-C(=O)- where m and n are independently 3 to 6 and R1 is O or S. (62) Divided Out of 549740
Patent NZ-581791-A (NZ)
Title: Stable formulations of thiadiazole derivative
Inventor: KUSANO HIROKO
IPC: A61K31/433
Filed: 2008-07-07
Abstract: The disclosure relates to a pharmaceutical composition comprising N-{ 4-(2,2-dimethyl-propiony1)-(5R)-5-[(2-ethylamino-ethanesulfonylamino)-methyl]-5-phenyl-4,5-dihydro-[1,3 ,4]thiadiazol-2-yl} -2,2-dimethyl-propionamide, a buffer and/or salt selected from tartrate, phosphate, citrate, mesylate, sodium phosphate, and sodium sulfate, and a pharmaceutically acceptable carrier, diluent, or excipient in aqueous solution wherein the pH of said composition is less than 5.4 and greater than 2.0 and contains no more than 2.0% N{ 4-(2,2-dimethyl-propiony1)-(5S)-5-[(2-ethylamino-ethanesulfonylamino)-methyl]-5-phenyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl} -2,2-dimethyl-propionamide and is stable to chiral conversion.
Patent NZ-582058-A (NZ)
Title: Valve and dispenser where the valve switches in response to pressure at the inlet and the outlet
Inventor: COPPLESTONE-BRUCE JOHN MERLIN
IPC: B67D7/30
Filed: 2008-05-29
Abstract: Disclosed is a valve (10) and a dispenser containing the valve. The valve has an inlet (11) and an outlet, and a valve element moveable between a first equilibrium position and a second open position, wherein when the valve element is in the first position, the inlet and the outlet are not in flow communication and when the valve element is in the second position the inlet and the outlet are in flow communication. The valve element is moveable reversibly from the first position to the second position and back by opposing fluid pressures at the inlet and the outlet.
Patent NZ-585833-A (NZ)
Title: Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
Inventor: CATENA RUIZ JUAN LORENZO
IPC: A61K31/439
Filed: 2008-11-26
Abstract: Disclosed is a D-tartrate salt of compound (1) ((R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid azabicyclo [2.2.2]oct-3-yl ester) possessing a stoichiometry of 1:1 of D-tartaric acid, and in the form of crystalline ploymorph I, is characterized as in the specification. Also disclosed is the use of said salt in the treatment of incontinence.
Patent NZ-587178-A (NZ)
Title: Methods and means for treating dna repeat instability associated genetic disorders
Inventor: DE KIMPE JOSEPHUS JOHANNES
IPC: A61P21/00
Filed: 2009-02-05
Abstract: Disclosed is the use of an oligonucleotide comprising an inosine, said oligonucleotide consisting of a sequence that is complementary only to a repetitive sequence element selected from (CAG)n, (GCG)n, (CUG)n, (CGG)n, (CCG)n, (GAA)n, (GCC)n and (CCUG)n in a gene transcript for the manufacture of a medicament. The medicament is used in the treatment or prevention of human cis-element repeat instability associated genetic disorders selected from Huntington's disease, Haw River syndrome, Kennedy's disease/spinobulbar muscular atrophy, spino-cerebellar ataxia, infantile spasm syndrome, deidocranial dysplasia, blepharophimosis/ptosis/epicanthus invensus syndrome, hand-foot-genital syndrome, synpolydactyly, oculopharyngeal muscular dystrophy, holoprosencephaly, myotonic dystrophy type 1, myotonic dystrophy type 2, Friedreich's ataxia, spino-cerebellar ataxia, autism, fragile X-syndromes, Jacobsen syndrome, myoclonus epilepsy, facioscapulohumeral dystrophy and certain forms of diabetes mellitus type 2.
Patent NZ-598959-A (NZ)
Title: Geothermal grout and method of preparing same
Inventor: KONCZAK JEFFREY JOHN
IPC: C04B14/00
Filed: 2009-09-21
Abstract: Disclosed is a method of installing a geothermal heating system comprising creating a bore hole in ground with said bore hole being located substantially in a Vadose Zone inserting at least one heat loop in said bore hole filling said bore hole with a grout material, including class F fly ash in a range of approximately 50-80 percent by weight of said grout material and cement kiln dust in a range of approximately 20-50 percent by weight of said grout material; allowing said grout material to harden.
Patent NZ-603487-A (NZ)
Title: Oxygenated butanol gasoline composition having good driveability performance
Inventor: BAUSTIAN JAMES J
IPC: C10L1/18
Filed: 2011-06-16
Abstract: Disclosed herein is a method for producing a butanol gasoline blend having good cold start and warm-up (CS&W) driveability performance comprising: (a) providing at least one biologically-sourced butanol isomer; and (b) blending said butanol isomer and optionally ethanol with gasoline to form a butanol gasoline blend, the butanol gasoline blend having a vapor pressure corresponding to a specific ASTM D4814 vapor pressure / distillation class of gasoline; wherein the butanol gasoline blend has a value of low butanol driveability index (LBDI) equal to the linear combination a1T10 + a2T50 + a3T90 + a4EtOH + BuOH (a5 – a6 E200) below the maximum limit for Driveability Index (DI) for the specific class of gasoline; wherein: T10 is the temperature for distillation of 10-volume percent of the butanol gasoline blend; T50 is the temperature for distillation of 50-volume percent of the butanol gasoline blend; T90 is the temperature for distillation of 90-volume percent of the butanol gasoline blend; EtOH is the concentration in volume percent of ethanol in the butanol gasoline blend; BuOH is the concentration in volume percent of the at least one biologically-sourced butanol isomer in the butanol gasoline blend; E200 is the volume percent of the butanol gasoline blend that distills at temperatures up to about 200 °F; the maximum limit for the Driveability Index (DI) for the specific class of gasoline is specified in Table 1 of ASTM D 4814-08a; and a1 is 1.5, a2 is 3, a3 is 1, and a4 is 2.4, and wherein a5 is 16 and a6 is 0.3 when the concentration of ethanol is less than 10 volume percent and the concentration of the at least one biologically-sourced butanol isomer is less than 20 volume percent; and wherein the total weighted demerits of the butanol gasoline blend is less than about 40.
Patent NZ-603733-A (NZ)
Title: Portable optical fiber distribution enclosure
Inventor: BURKE EDWARD J
IPC: G02B6/44
Filed: 2011-04-19
Abstract: 603733 An underground utility enclosure assembly with a sealed fiber distribution enclosure unit (22 Fig.2), includes a grade level box (24) and a removable cover (26, 28) that mounts to the box. The cover includes a removable plug (32 Fig.3) that provides access to the interior of the box. A removed plug area in the cover allows access to utility cables contained in the box and access to the interior of the sealed fiber distribution enclosure unit mounted to the open plug area. The bottom of the enclosure includes a rigid lower base frame section (42 Fig.2) that removably attaches to the open plug area, and an above-ground lower base ring (54 Fig.2) affixed to a cable opening passing through the base frame assembly. The sealed fiber distribution enclosure unit can be removed as a unit from the cover on the grade level box, with active cables undisturbed, and moved to a remote site for making above-ground fiber optic cable splices. The sealed fiber distribution enclosure unit then can be re- installed in the cover plate, with the active cables undisturbed.
Patent NZ-605462-A (NZ)
Title: High-frequency antenna
Inventor: THOMAS THIERRY
IPC: H01Q21/10
Filed: 2011-06-14
Abstract: Disclosed is an inductive antenna comprising at least two pairs of geometrically butted sections. Each section includes first and second parallel conductive elements insulated from each other. Each pair has, at each end, a single terminal of electric connection of its first conductive element to that of the adjacent pair. The pairs are either of a first type or a second type. In the first type (generally indicated as 3), the conductive elements are interrupted approximately in their middle to define the two sections. The first and second conductive elements of one section are connected to the second and first conductive element, respectively, of the other section of the pair. In the second type (generally indicated as 5), the first conductive element is interrupted approximately in its middle to define the two sections, and the second conductive element is not interrupted.
Patent NZ-614208-A (NZ)
Title: Auto-injector
Inventor: EKMAN MATTHEW
IPC: A61M5/32
Filed: 2012-02-16
Abstract: An auto-injector (1) for administering a dose of a liquid medicament (M) is disclosed. It is an object of the present invention to provide an improved auto-injector. One trigger button causes the injection to activate and then retract automatically after administering the medicament. The auto-injector comprising an elongate case (12) arranged to be held by a user with a tubular chassis (2) telescoped in the case (12) and biased against the case (12) so as to protrude from it. Additionally a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3) is contained within the case. A trigger button (13), distally arranged in or on the case (12), is initially coupled to the case (12) so as to protrude distally from the case (12) and interlocked to the chassis (2) in a manner preventing the trigger button (13) from disengaging the case (12) and thus preventing actuation of the trigger button (13) in an initial position. The case (12) is also arranged to translate in the proximal direction (P) against the bias relative to the chassis (2) when the chassis (2) is pressed against an injection site thereby also translating the trigger button (13) releasing the interlock to the chassis (2) so as to allow actuation of the trigger button (13). The trigger button (13) is arranged to lock in a more proximal position on actuation.
Patent NZ-619871-A (NZ)
Title: Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases
Inventor: ZHANG CHENGGANG
IPC: A61P1/04
Filed: 2012-01-19
Abstract: Disclosed use of a Salmonella flagellin protein derivative in the manufacture of a medicament for the treatment or prevention of an inflammatory bowel disease (IBD), wherein the protein derivative comprises the CLZC331 protein according to sequence ID NO:3 (as defined in the specification).
Patent NZ-620074-A (NZ)
Title: 2,5-disubstituted arylsulfonamide ccr3 antagonists
Inventor: LY TAI WEI
IPC: C07D295/26
Filed: 2010-04-21
Abstract: Disclosed herein is a compound of formula II, wherein the variables are defined in the specification, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer or tautomer thereof; and the use thereof in the treatment of a CCR3-related disorder, disease or condition, such as an inflammatory or immunoregulatory disorder or disease, asthma, rhinitis, an allergic disease, or an autoimmune pathology, or HIV, lung granuloma, or Alzheimer’s disease.
Patent NZ-631119-A (NZ)
Title: Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations
Inventor: ALEXANDER VERONICA J
IPC: C12N15/11
Filed: 2014-02-14
Abstract: Disclosed is the use of an ApoCIII specific inhibitor in the manufacture of a medicament for treating, preventing, delaying or ameliorating Familial Chylomicronemia Syndrome (FCS) or Lipoprotein Lipase Deficiency (LPLD) in an animal. Further disclosed is the use of an ApoCIII specific inhibitor in the manufacture of a medicament for preventing, delaying or ameliorating pancreatitis, or symptom thereof, in an animal with FCS or LPLD.
Patent NZ-702557-A (NZ)
Title: Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
Inventor: SCHELLENBERGER VOLKER
IPC: C12N15/18
Filed: 2013-03-14
Abstract: The present invention concerns an improved therapeutic regimen for GHD therapy. In particular, the invention concerns methods for bolus dose administration of a human growth hormone- XTEN (hGH-XTEN) fusion protein.
Patent NZ-705360-A (NZ)
Title: Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
Inventor: EMBRECHTS Werner
IPC: A61P31/12
Filed: 2013-10-03
Abstract: The present invention relates to acylaminopyrimidine derivatives and pharmaceutical compositions according to Formula I as defined in the specificaiton and claims. Also provided is the use of acylaminopyrimidine derivatives and pharmaceutical compositions according to Formula I in disorders involving the induction of interferon.
Patent NZ-713739-A (NZ)
Title: Patient alarm system and device therefor
Inventor: ALEXANDER WILLIAM WALKER
IPC: H01H3/24
Filed: 2015-10-29
Abstract: An activation device for a patient alarm system, the activation device comprising a resiliently deformable bladder defining an internal volume, and a pressure switch in fluid communication with the internal volume and connected to an alarm system, whereby squeezing the resiliently deformable bladder operates the pressure switch, which activates the alarm system.
Patent NZ-716183-A (NZ)
Title: Easily dissociable wheelchair
Inventor: BRENNER SIMON
IPC: A61G5/10
Filed: 2012-12-21
Abstract: A wheelchair (10) is disclosed. The wheelchair (10) comprises a seat module (10), a backrest module (20), a front frame module (30), and a rear wheel module (40). The seat module (10) includes a seat frame (see 11, figure 2) supporting a seat. The backrest module (20) includes a backrest frame (21) connected to the seat frame (11) and supports a backrest (22). The front frame module (30) includes a front frame (31). The front frame (31) includes left and right bended legs (31a, 31b) removably connected at their upper end to the seat frame (11) and at their lower end to a footrest (32). The bended legs (31a, 31b) are supported by caster wheel assemblies (35, 36) via caster supports (34). The rear wheel module (40) includes left and right rear wheels (41a, 41b) pivotally connected to an axle (42). The rear wheel module (40) is removably connected to the seat module (10) through left and right connecting elements (43a, 43b). The seat frame (11) consists of left and right longitudinal profiles (11a, 11b) extending in the same plane. The seat includes a seat plate (12) extending between the left and right profiles (11a, 11b) of the seat frame (see 11, figure 2) where the seat plate (12) is integral with the left and right profiles (11a, 11b).